This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other and unspecified injuries of ankle and foot
ST19_OTHER_UNSPE_INJURI_ANKLE_FOOT
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1685 |
4. Check minimum number of eventsNone |
1685 |
5. Include endpointsNone |
1685 |
6. Filter based on genotype QC (FinnGen only) |
1685 |
Control definitions (FinnGen only)
- Control exclude
- ST19_INJURI_ANKLE_FOOT
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- S90
- Name in latin
- Laesiones in regione tarsi/pedis aliae sive non specificatae
Similar endpoints
↥List of similar endpoints to
Other and unspecified injuries of ankle and foot
based on the number of shared cases.
Similar with more cases:
- Injuries to the ankle and foot
- Injury, poisoning and certain other consequences of external causes
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1685 | 1061 | 624 |
| Unadjusted period prevalence (%) | 0.33 | 0.36 | 0.28 |
| Median age at first event (years) | 44.44 | 41.95 | 48.67 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1509
- Matched controls
- 15090
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
S99.9
ICD-10 Finland
Unspecified injury of ankle and foot
879.9
323.0
1259
86
S99.8
ICD-10 Finland
Other specified injuries of ankle and foot
168.4
233.4
241
17
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
12.1
184.0
359
379
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
5.2
165.5
669
2013
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
11.6
153.5
303
319
S93.4
ICD-10 Finland
Sprain and strain of ankle
7.6
129.9
335
548
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
25.6
124.5
177
78
X59
ICD-10 Finland
Exposure to unspecified factor
4.5
114.3
499
1507
X58
ICD-10 Finland
Exposure to other specified factors
4.4
93.2
390
1099
W19
ICD-10 Finland
Unspecified fall
5.6
87.0
279
586
S92.3
ICD-10 Finland
Fracture of metatarsal bone
24.7
86.1
123
54
W22
ICD-10 Finland
Striking against or struck by other object(s)
5.9
68.5
207
398
NH1AD
NOMESCO Finland
Ankle and foot CT
15.6
58.7
98
67
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
9.2
55.9
121
142
M79.6
ICD-10 Finland
Pain in limb
2.4
49.9
583
3137
W10
ICD-10 Finland
Fall on and from stairs and steps
6.6
47.3
127
207
L16
ICPC
Ankle symptom/complaint
3.5
43.5
228
738
W00
ICD-10 Finland
Fall on same level involving ice and snow
3.4
39.2
209
682
S90.3
ICD-10 Finland
Contusion of other and unspecified parts of foot
10.4
39.0
78
79
L17
ICPC
Foot/toe symptom/complaint
2.4
38.9
426
2160
N02AX02
ATC
tramadol; systemic, rectal
2.1
38.7
589
3479
M25.5
ICD-10 Finland
Pain in joint
2.2
36.0
465
2531
S99.7
ICD-10 Finland
Multiple injuries of ankle and foot
+∞
35.6
34
*
S92.0
ICD-10 Finland
Fracture of calcaneus
+∞
33.5
32
*
N02BE01
ATC
paracetamol; systemic, rectal
2.2
32.3
1235
10184
S90.0
ICD-10 Finland
Contusion of ankle
10.7
31.3
61
59
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
4.6
30.2
110
256
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
30.0
586
3719
NG4AA
NOMESCO Finland
Lower leg X-ray examination
6.3
30.0
82
137
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.9
29.8
649
4281
NH2AA
NOMESCO Finland
Heel X-ray examination
29.9
28.6
38
13
J01DB01
ATC
cefalexin; oral
2.1
28.5
1225
10215
N03AX16
ATC
pregabalin; oral
2.2
28.1
335
1730
S82.6
ICD-10 Finland
Fracture of lateral malleolus
4.1
28.1
115
299
M54.5
ICD-10 Finland
Low back pain
1.9
27.4
512
3171
S06.0
ICD-10 Finland
Concussion
2.7
27.1
206
843
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
8.6
26.9
59
71
W17
ICD-10 Finland
Other fall from one level to another
4.3
26.3
100
243
S93.2
ICD-10 Finland
Rupture of ligaments at ankle and foot level
24.5
25.7
36
15
B01AB05
ATC
enoxaparin; parenteral
2.0
23.7
367
2092
S93.6
ICD-10 Finland
Sprain and strain of other and unspecified parts of foot
9.2
23.4
49
55
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
23.1
546
3614
S92.5
ICD-10 Finland
Fracture of other toe
6.4
22.0
58
93
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.3
21.7
216
1015
R51.80
ICD-10 Finland
Headache
2.1
21.6
268
1392
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
21.4
271
1420
N05AH04
ATC
quetiapine; oral
2.1
21.1
288
1553
J45.9
ICD-10 Finland
Asthma, unspecified
2.1
21.1
265
1382
SPAT1211
SPAT
Application of soft bandage
2.6
20.0
160
668
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.9
19.9
373
2262
S18
ICPC
Laceration/cut
1.7
19.7
534
3647
S80.0
ICD-10 Finland
Contusion of knee
2.8
19.4
129
482
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
3.4
19.3
95
289
J01MA12
ATC
levofloxacin; systemic
2.2
19.0
220
1103
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.1
18.9
235
1215
S92.1
ICD-10 Finland
Fracture of talus
+∞
18.8
18
*
SAA01
NOMESCO Finland
Simple examination of mouth
1.7
18.7
1088
9123
AA1AD
NOMESCO Finland
CT of head and brain
2.0
18.7
279
1552
M03BC01
ATC
orphenadrine (citrate); systemic
1.8
18.6
350
2118
S91.3
ICD-10 Finland
Open wound of other parts of foot
7.4
18.6
44
61
NHJ10
NOMESCO Finland
Internal fixation of fracture of ankle using wire, rod, cerclage or pin
3.7
18.5
81
225
TNH31
NOMESCO Finland
Prefabricated orthosis, ankle or foot
13.7
18.3
31
23
WX110
NOMESCO Finland
Local anesthesy
1.7
18.2
1060
8847
A02BC02
ATC
pantoprazole; systemic
1.6
18.1
817
6371
S92.2
ICD-10 Finland
Fracture of other tarsal bone(s)
33.3
18.0
23
7
M03BX02
ATC
tizanidine; oral
1.6
17.9
843
6633
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
17.9
737
5599
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.5
17.7
146
619
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.8
17.7
354
2182
S22.3
ICD-10 Finland
Fracture of rib
3.1
17.6
97
322
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.6
17.4
800
6235
S01.0
ICD-10 Finland
Open wound of scalp
2.9
17.2
108
389
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.1
17.2
99
338
L12
ICPC
Hand/finger symptom/complaint
2.0
17.1
236
1269
M01AH05
ATC
etoricoxib; oral
1.6
17.0
766
5927
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.6
16.8
128
518
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
16.6
500
3476
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
16.6
312
1881
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
6.9
16.6
41
61
R03AC02
ATC
salbutamol; inhalant
1.6
16.4
754
5841
Z3231
NOMESCO Finland
Registered nurse
1.7
16.4
384
2480
W52
ICD-10 Finland
Crushed, pushed or stepped on by crowd or human stampede
5.0
16.4
52
106
W20
ICD-10 Finland
Struck by thrown, projected or falling object(s)
7.3
16.3
39
55
P01AB01
ATC
metronidazole; oral, rectal
1.6
16.2
521
3681
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
3.0
16.2
97
339
A46
ICD-10 Finland
Erysipelas
2.3
16.1
164
773
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
16.0
347
2189
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.9
16.0
282
1661
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.1
15.9
188
950
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.5
15.9
132
563
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.9
15.8
247
1393
Y96.9
ICD-10 Finland
Unspecified type of accident
6.2
15.8
42
69
N03AX12
ATC
gabapentin; oral
2.1
15.6
192
984
Z00.8
ICD-10 Finland
Other general examinations
2.5
15.6
125
523
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.6
15.5
718
5546
M01AB05
ATC
diclofenac; systemic, rectal
1.6
15.5
879
7128
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.1
15.5
191
983
Z3226
NOMESCO Finland
Physiotherapist
1.9
15.3
260
1507
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.2
15.3
170
834
S82.8
ICD-10 Finland
Fractures of other parts of lower leg
3.8
15.3
65
177
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.7
15.2
108
420
R06.0
ICD-10 Finland
Dyspnoea
1.8
15.1
296
1802
W23
ICD-10 Finland
Caught, crushed, jammed or pinched in or between objects
7.1
14.9
36
52
L08
ICPC
Shoulder symptom/complaint
1.9
14.9
236
1337
S63.6
ICD-10 Finland
Sprain and strain of finger(s)
3.1
14.9
84
282
J01FF01
ATC
clindamycin; systemic
1.7
14.9
356
2305
S63.5
ICD-10 Finland
Sprain and strain of wrist
3.2
14.8
80
263
NH3AI
NOMESCO Finland
Cone beam CT of foot
80.9
14.6
16
*
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.2
14.3
75
241
M01AE01
ATC
ibuprofen; systemic, rectal
1.8
14.3
1321
11994
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.5
14.3
67
198
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.8
14.2
91
333
Y94.8
ICD-10 Finland
Other leisure activity accident
4.1
14.1
54
134
L28
ICPC
Limited function/disability (L)
2.1
14.0
166
837
S92.7
ICD-10 Finland
Multiple fractures of foot
53.8
13.8
16
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.2
13.8
144
685
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.2
13.8
142
674
M54.8
ICD-10 Finland
Other dorsalgia
3.2
13.8
73
237
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.0
13.6
175
915
TNG34
NOMESCO Finland
Major custom moulded orthopaedic cast, knee or lower leg
6.4
13.5
35
56
ZXD05
NOMESCO Finland
Urgent procedure
1.6
13.5
419
2902
WX320
NOMESCO Finland
Spinalanesthesy
1.8
13.4
269
1646
N06AB04
ATC
citalopram; systemic
1.8
13.4
272
1670
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
13.4
130
602
M54.4
ICD-10 Finland
Lumbago with sciatica
1.9
13.3
225
1299
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.9
13.3
220
1262
ZXE00
NOMESCO Finland
One hour or less
1.5
13.3
542
4016
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
13.3
261
1585
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
6.2
13.2
35
58
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
13.2
765
6129
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
13.2
120
535
SPAT1263
SPAT
Sampling
1.5
13.0
606
4625
ND1BA
NOMESCO Finland
Wrist extensive X-ray examination
4.5
12.5
44
101
J01AA02
ATC
doxycycline; systemic
1.5
12.5
980
8335
G44.2
ICD-10 Finland
Tension-type headache
1.9
12.4
198
1119
S62.6
ICD-10 Finland
Fracture of other finger
2.8
12.4
80
295
N06AX11
ATC
mirtazapine; oral
1.6
12.3
406
2844
NA1AD
NOMESCO Finland
Cervical spine CT examination
3.2
12.3
63
200
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.2
12.3
129
617
L15
ICPC
Knee symptom/complaint
1.7
12.3
268
1681
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.1
12.1
148
756
R07.3
ICD-10 Finland
Other chest pain
2.2
12.1
121
568
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
3.4
12.0
57
171
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
12.0
147
752
H02AB06
ATC
prednisolone; systemic
1.5
11.9
573
4376
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
11.9
315
2083
Z00.0
ICD-10 Finland
General medical examination
1.7
11.8
262
1648
L03
ICPC
Low back symptom/complaint
1.6
11.6
329
2217
R60.0
ICD-10 Finland
Localized oedema
2.2
11.6
113
525
ZXA05
NOMESCO Finland
Left side
1.7
11.5
273
1748
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
11.5
347
2375
WX002
NOMESCO Finland
Sedation and analgesia
1.8
11.5
226
1372
Z71.8
ICD-10 Finland
Other specified counselling
1.6
11.4
364
2523
M89.0
ICD-10 Finland
Algoneurodystrophy
7.9
11.4
25
32
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.0
11.3
150
791
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
11.2
310
2070
ZXA00
NOMESCO Finland
Right side
1.6
11.2
298
1971
N05BA04
ATC
oxazepam; oral
1.6
11.2
305
2028
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.6
11.1
372
2605
TQW40
NOMESCO Finland
Remowal of suture of skin
2.4
11.1
93
397
NHE15
NOMESCO Finland
Suture or reinsertion of ligament of ankle
11.2
11.0
20
18
SPAT1229
SPAT
Assessment of need for aid
2.5
10.9
84
346
F10.09
ICD-10 Finland
Alcohol intoxication UNS
4.0
10.8
42
107
A02BC01
ATC
omeprazole; systemic
1.6
10.8
318
2160
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
10.8
237
1484
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
2.7
10.7
73
281
S92.9
ICD-10 Finland
Fracture of foot, unspecified
28.2
10.7
14
5
L86
ICPC
Back syndrome with radiating pain
2.6
10.7
78
310
S60.0
ICD-10 Finland
Contusion of finger(s) without damage to nail
2.9
10.7
64
228
NG1BA
NOMESCO Finland
Knee extensive X-ray examination
4.4
10.6
37
85
NHJ50
NOMESCO Finland
Open reduction of fracture of foot or toe
60.4
10.6
12
*
N30.0
ICD-10 Finland
Acute cystitis
1.8
10.6
185
1075
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
10.6
428
3131
SPAT1153
SPAT
Removal of sutures
1.6
10.5
357
2506
SPAT1312
SPAT
General health counselling
1.5
10.5
481
3615
M77.4
ICD-10 Finland
Metatarsalgia
2.5
10.4
80
328
R02
ICPC
Shortness of breath/dyspnoea
1.9
10.4
153
843
Y94.2
ICD-10 Finland
Accident with sport
6.4
10.3
26
41
S69.9
ICD-10 Finland
Unspecified injury of wrist and hand
3.9
10.3
41
107
UJF32
NOMESCO Finland
Coloscopy
1.6
10.2
264
1728
S49.9
ICD-10 Finland
Unspecified injury of shoulder and upper arm
4.6
10.2
34
75
M70.6
ICD-10 Finland
Trochanteric bursitis
2.0
10.2
127
654
N03AG01
ATC
valproic acid; systemic, rectal
2.3
10.1
90
399
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.7
10.1
214
1324
L74
ICPC
Fracture: hand/foot bone
4.2
10.1
37
90
N06AX16
ATC
venlafaxine; oral
1.8
10.0
195
1175
N05CF01
ATC
zopiclone; oral
1.6
10.0
332
2317
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.4
10.0
815
6832
S20.2
ICD-10 Finland
Contusion of thorax
2.7
10.0
67
256
Z09.4
ICD-10 Finland
Follow-up examination after treatment of fracture
2.7
9.9
66
249
Y96.0
ICD-10 Finland
Work-related condition
5.1
9.9
30
60
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
2.8
9.8
62
229
N03AE01
ATC
clonazepam; systemic
2.5
9.8
76
315
N05AA02
ATC
levomepromazine; systemic
2.9
9.8
59
212
Z3229
NOMESCO Finland
Other healthcare associate professional
2.1
9.7
111
550
TNH33
NOMESCO Finland
Custom moulded brace, ankle or foot
5.2
9.7
29
57
M19.0
ICD-10 Finland
Primary arthrosis of other joints
2.1
9.7
104
503
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.6
9.7
302
2073
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
9.6
596
4733
SPAT1254
SPAT
Administration of medicine
1.7
9.6
206
1278
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
2.0
9.5
119
616
S89.9
ICD-10 Finland
Unspecified injury of lower leg
2.7
9.5
64
245
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.5
9.5
75
315
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
4.0
9.4
36
91
R42
ICD-10 Finland
Dizziness and giddiness
1.7
9.4
229
1470
S82.4
ICD-10 Finland
Fracture of fibula alone
4.6
9.4
31
68
G43.9
ICD-10 Finland
Migraine, unspecified
2.1
9.4
102
495
L29
ICPC
Musculoskeletal sympt/complt other
2.1
9.3
102
498
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
3.9
9.3
37
97
WX290
NOMESCO Finland
Other blockade of nerve
1.4
9.3
696
5714
N03AX09
ATC
lamotrigine; oral
2.3
9.3
85
384
M84.3
ICD-10 Finland
Stress fracture, not elsewhere classified
5.3
9.2
27
52
R96
ICPC
Asthma
2.0
9.2
114
587
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
2.5
9.2
67
270
W11
ICD-10 Finland
Fall on and from ladder
5.0
9.1
28
57
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
9.1
412
3071
SPAT1216
SPAT
Assessment of functional ability
1.8
9.1
151
864
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
2.9
9.0
54
193
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.9
9.0
140
783
S91.0
ICD-10 Finland
Open wound of ankle
10.1
9.0
17
17
E66.01
ICD-10 Finland
Obesity due to excess calories
2.0
9.0
115
600
K02.1
ICD-10 Finland
Caries of dentine
1.4
9.0
855
7304
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.6
9.0
253
1692
N06AB06
ATC
sertraline; oral
1.8
9.0
159
930
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.0
9.0
114
591
D11
ICPC
Diarrhoea
1.7
9.0
179
1086
TNX34
NOMESCO Finland
Major custom molded cast, unspecified region
5.1
9.0
27
54
SPAT1301
SPAT
No procedures
1.5
8.9
395
2925
W49
ICD-10 Finland
Exposure to other and unspecified inanimate mechanical forces
4.2
8.9
32
77
ND1AA
NOMESCO Finland
Wrist X-ray examination
2.3
8.9
79
351
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.0
8.9
112
582
R74
ICPC
Upper respiratory infection acute
1.4
8.9
470
3610
J01MA02
ATC
ciprofloxacin; systemic
1.5
8.9
426
3208
SGA01
NOMESCO Finland
Tooth opening as first aid
1.6
8.8
235
1551
M01AE02
ATC
naproxen; oral, rectal
1.4
8.8
799
6759
XQ800
NOMESCO Finland
Prick test
1.9
8.8
125
680
N06AX21
ATC
duloxetine; oral
1.9
8.8
134
745
H02AB04
ATC
methylprednisolone; systemic
1.8
8.8
161
955
TNH32
NOMESCO Finland
Custom moulded split, ankle or foot
6.0
8.8
23
39
A29
ICPC
General symptom/complaint other
1.9
8.7
134
747
N05BA01
ATC
diazepam; systemic, rectal
1.8
8.7
157
922
T74.1
ICD-10 Finland
Physical abuse
3.2
8.7
43
135
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.8
8.7
162
960
L76
ICPC
Fracture: other
3.5
8.7
38
109
J01FA09
ATC
clarithromycin; systemic
1.5
8.7
414
3111
L01
ICPC
Neck symptom/complaint
1.7
8.7
186
1152
TNX99
NOMESCO Finland
Other orthopaedic minor procedure
3.2
8.7
43
136
M01AE03
ATC
ketoprofen; systemic, rectal
1.5
8.6
410
3078
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
8.6
184
1138
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.7
8.6
166
996
N06AB03
ATC
fluoxetine; oral
1.8
8.6
159
945
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.6
8.6
225
1477
R11
ICD-10 Finland
Nausea and vomiting
2.0
8.5
111
583
R05
ICPC
Cough
1.5
8.5
295
2069
L02
ICPC
Back symptom/complaint
1.8
8.4
133
750
J45.1
ICD-10 Finland
Nonallergic asthma
2.1
8.4
97
484
J01DA01
ATC
[U] cefalexin; systemic
1.4
8.4
824
7042
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.9
8.3
121
662
K04.08
ICD-10 Finland
Other specified pulpit
2.0
8.3
109
573
S82.3
ICD-10 Finland
Fracture of lower end of tibia
3.5
8.3
37
108
S92.4
ICD-10 Finland
Fracture of great toe
7.1
8.3
19
27
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
4.8
8.3
26
55
N05AX08
ATC
risperidone; systemic
2.0
8.2
99
506
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.8
8.2
52
192
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
8.2
118
642
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.0
8.1
102
530
R53
ICD-10 Finland
Malaise and fatigue
1.6
8.1
256
1756
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
8.1
168
1033
W64
ICD-10 Finland
Exposure to other and unspecified animate mechanical forces
8.2
8.1
17
21
NH1FA
NOMESCO Finland
Weight-bearing X-ray of ankle
8.2
8.1
17
21
A80
ICPC
Trauma/injury NOS
4.9
8.1
25
52
J01MA14
ATC
moxifloxacin; systemic
2.0
8.1
101
522
I50.9
ICD-10 Finland
Heart failure, unspecified
2.1
8.0
91
454
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.4
8.0
493
3877
A28
ICPC
Limited function/disability NOS
1.9
8.0
123
688
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
2.6
8.0
56
221
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
2.2
8.0
79
371
K59.09
ICD-10 Finland
Constipation, unspecified
2.4
8.0
65
277
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.0
8.0
101
526
R03BA05
ATC
fluticasone; inhalant
1.6
8.0
245
1670
N06AA09
ATC
amitriptyline; systemic
2.0
8.0
101
527
S86.0
ICD-10 Finland
Injury of Achilles tendon
3.2
7.9
39
123
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.4
7.9
767
6509
S19
ICPC
Skin injury other
2.6
7.9
55
217
J02AC01
ATC
fluconazole; systemic
1.4
7.9
516
4103
L73
ICPC
Fracture: tibia/fibula
5.7
7.8
21
37
XF600
NOMESCO Finland
Bloodpressure measurement
2.1
7.8
85
417
F61.0
ICD-10 Finland
Mixed personality disorders
3.5
7.8
34
98
S52.5
ICD-10 Finland
Fracture of lower end of radius
1.9
7.8
109
587
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.4
7.8
523
4172
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
3.0
7.8
42
142
H53.1
ICD-10 Finland
Subjective visual disturbances
2.2
7.8
79
375
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
2.1
7.8
86
424
M13.9
ICD-10 Finland
Arthritis, unspecified
2.1
7.8
84
411
SPAT1283
SPAT
Restricted health certificate
1.5
7.7
331
2428
M48.0
ICD-10 Finland
Spinal stenosis
1.9
7.7
105
561
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
7.7
231
1564
M79.1
ICD-10 Finland
Myalgia
1.7
7.7
166
1028
S96.8
ICD-10 Finland
Injury of other muscles and tendons at ankle and foot level
15.1
7.7
12
8
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.7
7.7
49
182
SPAT1260
SPAT
Consultation of another employee
1.6
7.7
222
1492
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.6
7.7
207
1367
A01
ICPC
Pain general/multiple sites
2.0
7.7
96
497
T78.4
ICD-10 Finland
Allergy, unspecified
2.2
7.6
78
370
S61.9
ICD-10 Finland
Open wound of wrist and hand, part unspecified
2.8
7.6
47
173
J01CA04
ATC
amoxicillin; systemic
1.4
7.6
1206
11082
R05
ICD-10 Finland
Cough
1.6
7.6
231
1568
S90.9
ICD-10 Finland
Superficial injury of ankle and foot, unspecified
18.4
7.6
11
6
N06AB10
ATC
escitalopram; oral
1.5
7.6
287
2047
TND32
NOMESCO Finland
Custom moulded splint, wrist or hand
5.0
7.6
23
47
ZXD35
NOMESCO Finland
Usual procedure
2.8
7.6
48
177
S93.3
ICD-10 Finland
Dislocation of other and unspecified parts of foot
25.1
7.6
10
*
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
1.8
7.6
124
707
SPAT1310
SPAT
Counselling related to known health issue
1.4
7.6
431
3335
P15
ICPC
Chronic alcohol abuse
3.0
7.5
43
148
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.6
7.5
192
1247
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.1
7.5
84
416
TNX39
NOMESCO Finland
Other orthopedic bandage, unspecified region
4.0
7.5
28
71
N05AH03
ATC
olanzapine; systemic
2.0
7.4
88
445
M54.3
ICD-10 Finland
Sciatica
2.2
7.4
72
335
R21
ICPC
Throat symptom/complaint
1.4
7.4
356
2669
R03BB04
ATC
tiotropium bromide; inhalant
2.0
7.4
90
461
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.7
7.4
152
933
X50
ICD-10 Finland
Overexertion and strenuous or repetitive movements
3.2
7.4
37
119
-1
NOMESCO Finland
NA
1.4
7.4
522
4193
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
7.3
257
1803
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
7.3
169
1072
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
3.5
7.3
32
93
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
4.0
7.3
27
68
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
2.4
7.3
60
258
Z2446
NOMESCO Finland
Social worker
1.9
7.2
103
562
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
7.2
250
1751
R03BA02
ATC
budesonide; inhalant
1.5
7.2
222
1513
L81
ICPC
Injury musculoskeletal NOS
3.2
7.1
35
111
R50.9
ICD-10 Finland
Fever, unspecified
1.6
7.1
179
1157
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
3.0
7.1
38
128
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
3.0
7.1
39
134
S09.9
ICD-10 Finland
Unspecified injury of head
5.1
7.1
21
42
C07AB07
ATC
bisoprolol; oral
1.4
7.1
425
3314
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.5
7.1
242
1686
SPAT1291
SPAT
Other function in accordance with NCSP classification
3.9
7.1
27
70
R33
ICD-10 Finland
Retention of urine
2.3
7.1
62
277
NHL30
NOMESCO Finland
Suture or reinsertion of tendon of foot
8.8
7.0
14
16
S83.6
ICD-10 Finland
Sprain and strain of other and unspecified parts of knee
2.1
7.0
74
357
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.7
7.0
137
827
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.8
7.0
42
152
S90.1
ICD-10 Finland
Contusion of toe(s) without damage to nail
3.1
7.0
36
118
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.4
7.0
327
2434
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
7.0
230
1593
H11.3
ICD-10 Finland
Conjunctival haemorrhage
2.9
7.0
40
139
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.4
7.0
320
2376
X57
ICD-10 Finland
Unspecified privation
3.1
7.0
36
119
EBA30
NOMESCO Finland
Excision of root of tooth
2.3
6.9
61
272
R01AD12
ATC
fluticasone furoate; nasal
1.4
6.9
417
3255
A06AD11
ATC
lactulose; oral
1.7
6.9
127
754
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.1
6.9
73
355
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
6.8
532
4325
NHA30
NOMESCO Finland
Exploration of joint of ankle or foot, arthroscopic
8.3
6.8
14
17
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.7
6.8
153
964
Z50.1
ICD-10 Finland
Other physical therapy
2.3
6.8
61
276
QDB00
NOMESCO Finland
Suture of skin of lower limb
6.7
6.8
16
24
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.7
6.8
138
842
M01AH01
ATC
celecoxib; oral (coxibs)
1.6
6.8
176
1151
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
6.8
1001
8969
S50.0
ICD-10 Finland
Contusion of elbow
2.7
6.8
44
167
NB3AA
NOMESCO Finland
Clavicle X-ray examination
3.9
6.8
26
68
F10.25
ICD-10 Finland
Alcohol dependence continuous use
3.7
6.8
27
73
NHK99
NOMESCO Finland
Other operation on bone of ankle or foot
3.7
6.8
27
73
Y09
ICD-10 Finland
Assault by unspecified means
6.1
6.8
17
28
S99
ICD-10 Finland
Other and unspecified injuries of ankle and foot
40.2
6.8
8
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.2
6.8
65
303
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
3.0
6.7
36
122
S21
ICPC
Skin texture symptom/complaint
1.7
6.7
149
935
Z01.2
ICD-10 Finland
Dental examination
1.3
6.7
598
4963
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.8
6.7
103
578
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
6.7
161
1030
R4110
NOMESCO Finland
Physiotherapy
1.4
6.7
296
2179
R04.0
ICD-10 Finland
Epistaxis
2.1
6.7
70
340
R83
ICPC
Respiratory infection other
1.4
6.7
395
3067
TQW11
NOMESCO Finland
Vacuum treatment of wound
3.7
6.7
27
74
R01AD09
ATC
mometasone; nasal
1.3
6.7
594
4931
C05AA01
ATC
hydrocortisone; rectal, topical
2.4
6.7
51
213
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.0
6.6
76
382
L84
ICPC
Back syndrome without radiat pain
2.3
6.6
57
253
Z04.3
ICD-10 Finland
Examination and observation following other accident
3.2
6.6
32
101
M54.2
ICD-10 Finland
Cervicalgia
2.0
6.6
86
452
M51.9
ICD-10 Finland
Intervertebral disc disorder, unspecified
4.2
6.6
23
55
KMAK
NOMESCO Finland
NA
1.3
6.6
716
6115
C03CA01
ATC
furosemide; systemic
1.5
6.6
200
1355
S29
ICPC
Skin symptom/complaint other
1.6
6.6
193
1301
A03FA01
ATC
metoclopramide; systemic, rectal
1.5
6.6
214
1475
S92
ICD-10 Finland
Fracture of foot, except ankle
12.3
6.6
11
9
J46
ICD-10 Finland
Status asthmaticus
2.8
6.6
39
141
R01BA52
ATC
pseudoephedrine, combinations; oral
1.4
6.5
328
2473
A03
ICPC
Fever
1.5
6.5
257
1848
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
6.5
433
3429
L18
ICPC
Muscle pain
2.4
6.5
53
229
L11
ICPC
Wrist symptom/complaint
1.8
6.5
115
673
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.6
6.5
159
1024
S80.1
ICD-10 Finland
Contusion of other and unspecified parts of lower leg
2.7
6.5
42
159
Y94.0
ICD-10 Finland
Accident at home
3.8
6.5
25
66
R52.9
ICD-10 Finland
Pain, unspecified
1.8
6.5
99
555
R03DC03
ATC
montelukast; oral
1.5
6.5
203
1390
K07
ICPC
Swollen ankles/oedema
2.9
6.5
37
129
N02AA05
ATC
oxycodone; systemic
1.7
6.4
118
700
H04.10
ICD-10 Finland
Dry eye syndrome
1.8
6.4
104
595
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
4.7
6.4
20
43
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.7
6.4
123
741
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
3.9
6.4
24
62
S15
ICPC
Foreign body in skin
2.0
6.4
74
375
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
6.3
441
3515
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
1.7
6.3
140
875
P03
ICPC
Feeling depressed
1.6
6.3
154
988
SPAT1255
SPAT
Intravenous administration of medicine
2.1
6.3
71
352
J01FA06
ATC
roxithromycin; oral
1.4
6.3
459
3682
NHQ40
NOMESCO Finland
Amputation of toe
6.0
6.3
16
27
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.9
6.3
84
449
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
6.3
75
382
S96.9
ICD-10 Finland
Injury of unspecified muscle and tendon at ankle and foot level
26.8
6.2
8
*
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.0
6.2
75
385
T90
ICPC
Diabetes non-insulin dependent
1.5
6.2
193
1319
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.8
6.2
109
638
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.1
6.2
66
323
M24.2
ICD-10 Finland
Disorder of ligament
3.8
6.2
24
64
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.8
6.2
94
524
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
6.2
971
8716
G47.3
ICD-10 Finland
Sleep apnoea
1.5
6.1
220
1550
N05CD07
ATC
temazepam; oral
1.8
6.1
103
594
UDC00
NOMESCO Finland
Ear microscopy
1.8
6.1
94
527
R55
ICD-10 Finland
Syncope and collapse
1.8
6.1
110
648
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.1
6.1
68
339
SPAT1131
SPAT
Colonoscopy
2.7
6.1
40
153
J01EA01
ATC
trimethoprim; systemic
1.4
6.1
287
2135
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
6.1
482
3913
Z2445
NOMESCO Finland
Psychologist
2.0
6.1
76
396
R06.2
ICD-10 Finland
Wheezing
2.1
6.1
61
292
E0000UV
ATC
NA
1.3
6.1
518
4257
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.8
6.1
106
621
TNX30
NOMESCO Finland
Soft bandage, unspecified region
4.2
6.0
21
51
W55
ICD-10 Finland
Bitten or struck by other mammals
2.4
6.0
47
200
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023368) Bacteria identified in Blood by Culture
459
2777
1.90
27.71
4.7
3.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
949
7133
1.76
27.49
5.5
4.5
mmol/l
6.6
6.5
0.49
897
6519
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
780
5559
1.75
27.16
7.4
6.3
mmol/l
1.2
1.2
0.66
664
4710
(3002582) Erythrocytes [#/volume] in Urine
545
3558
1.79
25.32
3.8
3.0
e6/l
26.2
87.7
1.52
451
2684
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
571
3781
1.77
25.25
3.2
2.4
u/l
52.0
56.4
2.23
539
3521
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
707
5018
1.70
24.10
7.1
5.8
mmol/l
1.2
1.2
0.01
642
4573
(3026008) Bacteria identified in Urine by Culture
532
3491
1.77
24.04
3.4
2.6
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
828
6167
1.67
23.25
5.9
5.8
umol/l
11.2
11.1
0.05
781
5815
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
588
4020
1.71
22.67
4.1
3.0
ng/l
158.5
50.3
0.48
371
2344
(3013707) Erythrocyte sedimentation rate by Westergren method
1169
9572
1.72
22.56
4.7
3.7
mm/h
10.9
10.0
1.45
1091
8908
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1540
13777
2.37
22.46
16.8
11.1
mg/l
19.6
21.3
1.43
1291
10575
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
303
1701
1.95
22.38
2.0
1.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
606
4189
1.70
22.36
9.0
7.0
inr
1.2
1.2
0.52
224
1329
(3026782) Osmolality of Urine
376
2273
1.84
22.09
3.2
2.6
mosm/kgh2o
554.9
557.7
0.08
328
1938
(3000850) Epithelial cells [#/volume] in Urine
387
2424
1.77
19.97
3.1
2.4
e6/l
7.3
6.9
0.22
341
2135
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1155
9581
1.65
19.60
8.0
6.8
u/l
79.3
77.1
0.91
1098
9028
(3030467) Casts [#/volume] in Urine by Automated count
482
3235
1.69
19.30
3.8
2.9
e6/l
0.4
0.4
0.10
383
2390
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
472
3228
1.64
17.24
2.6
2.1
u/l
194.3
208.5
0.15
449
3052
(3031040) Bacteria [#/volume] in Urine by Automated count
1050
8644
1.57
17.12
5.4
3.9
e6/l
3201.2
2325.3
0.21
16
112
(3018095) Leukocytes [#/volume] in Urine
601
4375
1.58
16.88
4.3
3.4
e6/l
65.3
88.9
0.73
469
2929
(42870588) Differential panel, method unspecified - Blood
601
4389
1.57
16.57
6.7
6.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1487
13421
1.92
16.54
18.0
12.0
mmol/l
139.5
139.6
0.75
1462
13042
(3022217) INR in Platelet poor plasma by Coagulation assay
203
1101
1.96
16.30
20.1
18.7
inr
1.1
1.3
1.57
39
176
(3009343) pH of Capillary blood
150
731
2.15
16.11
5.2
4.1
ph
7.4
7.4
0.19
16
88
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
420
2833
1.64
16.03
1.8
1.8
mg/l
0.7
1.0
4.79
303
2057
(3023103) Potassium [Moles/volume] in Serum or Plasma
1487
13462
1.89
15.79
18.1
12.0
mmol/l
3.9
3.9
0.37
1461
13055
(36304419) Bacteria [Presence] in Urine
465
3228
1.61
15.75
3.8
2.8
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
150
738
2.13
15.72
5.2
4.1
kpa
5.2
5.1
0.17
136
698
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
600
4425
1.55
15.62
3.3
3.2
u/l
31.8
30.6
0.48
578
4211
(3006504) Eosinophils/100 leukocytes in Blood
810
6375
1.52
15.61
6.8
5.9
%
2.8
2.8
0.05
756
5955
(3019069) Monocytes/100 leukocytes in Blood
812
6420
1.51
15.15
7.0
6.2
%
8.2
8.3
0.38
754
6045
(3002030) Lymphocytes/100 leukocytes in Blood
835
6670
1.50
14.64
6.8
5.9
%
29.8
29.5
0.26
779
6267
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1389
12396
1.69
14.62
13.7
9.8
ml/min/173m2
90.4
89.8
0.36
1171
9951
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
143
712
2.10
14.52
5.2
4.1
mmol/l
1.9
1.7
0.27
102
514
(3022096) Basophils/100 leukocytes in Blood
779
6156
1.49
14.27
6.9
6.0
%
0.7
0.7
0.95
729
5771
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
100
435
2.38
14.08
2.3
1.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1081
9149
1.51
13.98
5.0
3.9
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
149
767
2.03
13.83
1.8
1.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
820
6581
1.48
13.70
6.7
5.7
%
55.7
56.1
0.34
767
6199
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1254
10985
1.55
13.53
3.8
3.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
288
1833
1.69
13.53
3.2
2.7
e6/l
4.8
2.7
1.38
182
968
(3018418) pH of Serum or Plasma
454
3241
1.55
13.26
4.7
3.6
ph
7.4
7.4
0.13
111
635
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
92
399
2.38
13.05
2.1
1.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
935
7747
1.46
12.98
9.3
8.9
e9/l
4.1
3.9
1.55
825
6798
(3013115) Eosinophils [#/volume] in Blood
858
7006
1.46
12.77
6.8
6.2
e9/l
0.2
0.2
0.51
770
6219
(3010421) pH of Blood
73
287
2.61
12.75
3.8
3.4
ph
7.4
7.4
0.53
61
240
(3020564) Creatinine [Moles/volume] in Serum or Plasma
1547
14389
1.92
12.20
17.2
12.3
umol/l
73.9
72.7
0.82
1547
14384
(3024561) Albumin [Mass/volume] in Serum or Plasma
627
4855
1.46
12.14
5.7
4.8
g/l
35.9
36.6
2.17
588
4520
(3006315) Basophils [#/volume] in Blood
830
6776
1.44
12.13
6.7
5.9
e9/l
0.0
0.0
0.48
729
5920
(3012501) Base excess in Blood by calculation
64
243
2.70
11.98
4.0
3.5
mmol/l
2.0
2.4
0.56
34
151
(3021589) Normoblasts [#/volume] in Blood
750
6018
1.44
11.98
10.7
8.6
e9/l
0.0
0.0
0.43
631
4925
(3001604) Monocytes [#/volume] in Blood
823
6748
1.43
11.52
6.6
5.9
e9/l
0.6
0.6
3.11
723
5892
(3002179) Metamyelocytes/100 leukocytes in Blood
168
962
1.83
11.34
4.2
3.9
%
0.8
0.5
0.95
39
199
(3017181) Myelocytes/100 leukocytes in Blood
179
1045
1.80
11.33
4.2
4.3
%
1.1
0.8
0.41
51
276
(3019198) Lymphocytes [#/volume] in Blood
849
7014
1.42
11.32
6.7
5.9
e9/l
2.1
2.0
0.42
758
6250
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
289
1921
1.61
11.30
3.2
2.6
e6/l
1.1
1.0
0.06
182
1053
(3044640) Blood type and Crossmatch panel - Blood
519
3921
1.47
11.21
2.5
2.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
245
1566
1.66
11.20
2.3
1.9
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
409
2949
1.51
11.12
2.9
2.5
umol/l
3642.6
5225.9
0.35
357
2618
(3013512) EKG study
418
3028
1.51
11.12
3.9
3.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1208
10666
1.47
11.04
4.4
3.9
pmol/l
14.4
14.6
0.94
1110
9817
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
356
2503
1.54
10.87
3.3
2.9
ng/l
1604.9
971.9
1.66
281
2057
(3021440) Promyelocytes/100 leukocytes in Blood
172
1006
1.79
10.82
4.3
4.3
%
0.1
0.1
0.83
48
257
(3028707) Methadone [Presence] in Urine by Screen method
93
442
2.17
10.66
3.0
2.9
—
—
—
0
0
(3035941) MCH [Entitic mass]
1643
15725
2.80
10.65
23.3
16.3
pg
30.1
30.1
0.20
1627
15534
(3024731) MCV [Entitic volume]
1643
15726
2.80
10.63
23.3
16.3
fl
90.2
90.0
1.42
1627
15536
(3026361) Erythrocytes [#/volume] in Blood
1643
15729
2.79
10.57
23.4
16.4
e12/l
4.5
4.6
1.69
1611
15336
(3003458) Phosphate [Moles/volume] in Serum or Plasma
232
1485
1.65
10.52
7.7
5.8
mmol/l
1.1
1.1
0.12
219
1386
(3010813) Leukocytes [#/volume] in Blood
1643
15732
2.78
10.51
23.5
16.4
e9/l
6.9
6.7
1.69
1611
15339
(3005322) IgE [Units/volume] in Serum or Plasma
169
992
1.78
10.50
1.3
1.3
u/ml
173.3
218.3
0.66
164
918
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
332
2318
1.54
10.42
1.4
1.2
iu/ml
27.8
26.9
0.04
97
709
(3007461) Platelets [#/volume] in Blood
1641
15708
2.71
10.42
23.4
16.4
e9/l
259.4
256.7
0.99
1610
15340
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
303
2076
1.56
10.35
2.1
1.7
%
1.6
1.4
3.24
268
1870
(3000963) Hemoglobin [Mass/volume] in Blood
1643
15740
2.76
10.34
23.5
16.5
g/l
135.5
136.5
2.03
1628
15545
(3025159) Blasts/100 leukocytes in Blood
163
954
1.78
10.22
4.4
4.4
%
0.0
0.8
0.86
41
214
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
221
1407
1.66
10.22
2.8
2.8
umol/l
8.8
7.5
0.33
181
1211
(3020191) Ethanol [Moles/volume] in Serum or Plasma
37
113
3.33
10.15
2.2
1.5
promille
1.5
1.2
0.64
30
95
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
421
3104
1.47
10.13
2.6
2.1
mg/l
2.9
2.8
0.33
363
2666
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
477
3603
1.45
10.13
1.4
1.3
u/ml
1.7
1.7
0.04
121
959
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
662
5308
1.41
10.08
2.7
2.2
nmol/l
73.1
74.4
0.55
606
4871
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
314
2184
1.54
10.00
1.4
1.2
u/ml
6.0
10.5
1.33
114
885
(40768797) Stomach Pathology biopsy report
249
1652
1.60
9.73
1.4
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1367
12481
1.50
9.59
4.2
3.7
mmol/l
5.8
5.8
1.23
1257
11568
(40761511) CBC panel - Blood by Automated count
1549
14581
1.77
9.37
14.9
10.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
152
895
1.77
9.34
4.5
3.4
mmol/l
1.2
1.2
1.10
132
765
(3014111) Lactate [Moles/volume] in Serum or Plasma
155
921
1.75
9.23
7.5
7.7
mmol/l
1.4
1.4
0.13
150
879
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
74
341
2.22
9.19
2.6
2.2
ug/l
485.1
278.5
0.48
68
317
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
741
6121
1.38
9.18
4.3
3.9
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
288
2006
1.53
9.04
3.6
3.3
ng/l
97.1
481.1
3.66
179
1341
(3015235) Bicarbonate [Moles/volume] in Capillary blood
61
261
2.39
8.99
6.1
2.9
mmol/l
25.3
24.8
0.29
51
237
(3021960) Folate [Moles/volume] in Serum or Plasma
340
2455
1.48
8.97
1.8
1.4
nmol/l
18.2
20.6
2.72
289
2138
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1542
14524
1.73
8.94
11.0
8.8
u/l
27.3
26.6
0.78
1496
14071
(3033658) Prothrombin time (PT) actual/Normal
408
3060
1.44
8.82
4.3
3.8
%
90.8
93.2
1.11
395
2979
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1363
12501
1.47
8.73
5.3
4.5
mu/l
1.8
2.1
0.80
1261
11660
(3007164) IgA [Mass/volume] in Serum or Plasma
413
3124
1.43
8.48
1.6
1.5
g/l
2.2
2.3
0.05
236
1956
(3019225) pH of Specimen
171
1071
1.66
8.40
4.5
3.6
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
31
96
3.27
8.36
2.7
2.9
%
64.3
54.4
1.62
19
68
(3009466) Valproate [Moles/volume] in Serum or Plasma
50
202
2.52
8.35
6.9
5.6
umol/l
380.6
378.3
0.03
43
179
(3012095) Magnesium [Moles/volume] in Serum or Plasma
258
1786
1.52
8.30
4.6
3.8
mmol/l
0.8
0.8
2.06
234
1671
(3015377) Calcium [Moles/volume] in Serum or Plasma
489
3822
1.39
8.29
3.3
3.2
mmol/l
2.3
2.4
0.73
429
3415
(3037522) Nuclear Ab [Titer] in Serum
273
1916
1.51
8.23
1.5
1.3
titre
454.9
524.9
0.33
67
361
(3022948) Iron [Moles/volume] in Serum or Plasma
260
1813
1.51
8.07
2.7
2.3
umol/l
13.3
14.0
0.78
240
1674
(3004789) Transferrin [Mass/volume] in Serum or Plasma
240
1653
1.53
7.89
2.7
2.2
g/l
2.4
2.4
0.07
214
1530
(3036481) Cortisol [Moles/volume] in Serum or Plasma
193
1266
1.59
7.87
2.0
2.1
nmol/l
388.4
381.1
0.18
182
1176
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
121
704
1.77
7.76
2.0
1.8
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
51
217
2.39
7.65
2.5
2.5
%
16.8
16.9
0.05
21
111
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
93
501
1.91
7.63
5.0
4.5
mmol/l
24.6
24.8
0.31
88
479
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
466
3658
1.38
7.58
1.9
1.7
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
130
778
1.73
7.56
3.7
4.1
ng/l
81.5
76.7
0.29
110
702
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1256
11446
1.38
7.53
5.5
4.6
mmol/mol
39.1
38.4
1.42
1169
10740
(44816559) Phosphatidylethanol [Mass/volume] in Blood
68
329
2.11
7.53
1.3
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
55
244
2.30
7.52
4.7
3.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1073
9546
1.34
7.50
3.9
2.9
u/l
52.4
41.6
1.92
1010
9063
(3022313) Gas panel - Capillary blood
101
565
1.84
7.38
5.3
4.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
277
1991
1.47
7.38
2.9
2.6
ug/g
163.0
112.7
0.74
213
1597
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
160
1023
1.62
7.25
2.4
2.4
u/l
2364.2
6447.0
2.10
58
404
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
175
1150
1.58
7.08
3.9
4.2
u/l
246.1
252.6
0.15
166
1086
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
218
1506
1.51
7.05
2.9
2.3
%
22.8
23.9
0.47
187
1302
(3000991) Gas panel - Venous blood
148
935
1.64
7.04
9.5
8.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
449
3541
1.37
7.01
3.8
3.3
mmol/l
7.7
8.0
0.83
364
3050
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
101
575
1.80
6.99
1.7
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
120
719
1.72
6.97
3.9
2.9
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
253
1812
1.47
6.84
2.0
1.7
nmol/l
1072.5
1193.1
1.20
194
1382
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
387
2992
1.38
6.82
2.4
2.1
—
—
—
0
0
(4198724)
28
93
3.04
6.78
1.8
1.9
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
133
826
1.66
6.76
3.0
2.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
176
1174
1.56
6.67
2.6
2.3
u/l
36.5
35.8
0.04
148
991
(3027945) Reticulocytes/100 erythrocytes in Blood
171
1134
1.57
6.65
2.8
3.0
%
1.9
1.7
0.68
148
1017
(3002032) Base excess in Venous blood by calculation
154
1000
1.59
6.56
5.1
4.6
mmol/l
1.4
1.8
0.62
135
806
(3005719) IgG [Mass/volume] in Serum or Plasma
157
1028
1.58
6.46
2.4
2.8
g/l
10.7
10.5
0.24
146
948
(3021601) Nitrite [Presence] in Urine by Test strip
766
6589
1.30
6.37
5.2
4.4
estimate
0.0
0.0
0.50
200
1302
(3021901) Oxygen saturation in Capillary blood
43
185
2.36
6.35
5.2
2.6
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
33
125
2.67
6.33
1.6
1.6
%
56.7
59.9
0.14
14
85
(3041096) Erythrocytes [Presence] in Urine by Automated
472
3802
1.34
6.31
3.5
2.8
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
764
6576
1.30
6.30
3.9
3.2
estimate
0.0
0.0
0.50
189
1266
(3017732) Neutrophils [#/volume] in Blood
140
898
1.61
6.28
2.4
2.4
e9/l
3.9
4.0
0.34
106
744
(36660697) Celiac disease serology panel - Serum
186
1274
1.52
6.25
1.3
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
546
4498
1.32
6.22
2.1
1.8
pmol/l
95.6
96.3
0.15
307
2392
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
395
3104
1.36
6.22
2.5
2.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
161
1078
1.55
6.01
2.7
2.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
39
165
2.40
5.99
2.5
3.2
%
0.8
1.1
0.30
26
136
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
106
642
1.69
5.95
1.5
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
767
6641
1.28
5.92
4.0
3.2
estimate
0.0
0.0
0.30
192
1250
(3027008) Opiates [Presence] in Urine
161
1082
1.54
5.91
2.7
2.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
31
118
2.66
5.91
3.6
3.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
363
2838
1.36
5.87
2.5
2.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
167
1135
1.52
5.83
3.5
2.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
161
1086
1.53
5.82
2.8
2.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
68
363
1.91
5.80
2.0
1.9
ug/l
1.1
1.9
0.41
62
325
(3008757) Leukocyte morphology finding [Identifier] in Blood
31
120
2.61
5.73
3.6
4.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
53
262
2.06
5.62
1.5
1.3
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
12
25
4.83
5.49
1.1
1.0
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
125
807
1.59
5.48
1.7
1.9
g/l
1.3
1.3
0.01
115
751
(40761536) Microorganisms panel - Urine sediment
172
1195
1.49
5.41
4.6
3.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
157
1073
1.51
5.35
8.5
8.4
mmol/l
0.6
1.2
1.11
128
850
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
168
1166
1.49
5.31
1.9
1.7
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
93
562
1.69
5.29
1.5
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
432
3514
1.31
5.25
4.5
3.5
estimate
0.0
0.0
1.28
195
1264
(3001122) Ferritin [Mass/volume] in Serum or Plasma
754
6579
1.26
5.25
3.2
2.8
ug/l
92.5
94.8
0.15
695
6159
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
34
144
2.39
5.24
1.1
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
147
995
1.52
5.24
2.9
2.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
409
3305
1.31
5.22
6.5
6.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
190
1362
1.45
5.10
1.4
1.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
13
31
4.22
5.09
6.5
4.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
62
337
1.87
5.05
3.5
3.2
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
10
19
5.29
5.04
2.2
2.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
168
1179
1.47
5.03
1.9
1.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
298
2311
1.35
5.03
1.7
1.6
pmol/l
54000416.4
31896980.5
0.23
250
1972
(3027944) Amphetamines [Presence] in Urine
155
1072
1.49
4.99
2.4
2.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1284
11986
1.30
4.91
19.3
13.7
%
13.6
13.4
1.35
1263
11743
(3008898) HLA-B27 [Presence]
100
629
1.63
4.90
1.1
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
60
326
1.87
4.90
1.4
1.4
ug/g
290.8
305.1
0.20
38
179
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
18
56
3.24
4.90
3.8
3.6
umol/l
153.9
167.1
0.06
11
31
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
28
112
2.53
4.88
1.2
1.3
u/ml
0.6
1.0
0.20
13
43
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
73
423
1.76
4.85
1.6
1.6
g/l
0.2
0.2
0.13
68
397
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
599
5123
1.26
4.83
4.1
3.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
96
603
1.63
4.74
1.3
2.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
83
508
1.67
4.54
9.2
11.5
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
23
87
2.67
4.49
1.7
1.4
%
40.7
33.4
—
9
56
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
152
1073
1.46
4.44
3.7
2.4
g/l
0.2
0.2
1.05
141
1012
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
116
777
1.53
4.37
2.4
2.2
ug/l
6.4
7.1
0.18
101
691
(3023520) Reticulocytes [#/volume] in Blood
119
803
1.52
4.34
2.8
2.7
e9/l
78.4
71.0
0.86
91
598
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
82
507
1.65
4.33
2.1
2.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
33
151
2.21
4.32
1.6
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
197
1465
1.39
4.31
2.1
1.6
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
24
95
2.55
4.30
1.1
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
25
101
2.50
4.30
2.5
2.6
—
—
—
0
0
(3044889) 12 lead EKG panel
935
8475
1.23
4.27
3.6
3.1
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
17
56
3.06
4.24
1.7
1.1
u/l
201.6
472.2
0.68
17
48
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
43
220
1.98
4.23
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
43
220
1.98
4.23
1.2
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
33
153
2.18
4.19
1.6
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
30
134
2.26
4.16
1.1
1.3
nmol/l
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
72
435
1.68
4.16
1.6
1.6
g/l
1.1
1.2
0.73
67
406
(3025941) Bacteria identified in Stool by Culture
117
795
1.51
4.14
1.4
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
489
4145
1.25
4.14
2.2
2.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
33
154
2.17
4.13
1.6
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
77
476
1.65
4.09
1.3
1.2
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
93
604
1.57
4.04
10.4
9.8
%
93.6
94.2
0.38
93
599
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
93
606
1.57
3.99
10.4
9.8
%
0.7
0.7
0.19
93
601
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
66
396
1.69
3.93
1.6
2.1
g/l
1.4
1.4
0.02
60
350
(3000494) Fungus identified in Specimen by Culture
197
1488
1.37
3.93
1.6
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
32
151
2.14
3.91
1.6
1.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
126
880
1.47
3.91
1.3
1.5
iu/l
19.1
23.8
1.04
115
720
(3045414) Leukocytes [Presence] in Urine
90
587
1.56
3.85
2.1
1.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
32
152
2.13
3.85
1.6
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
32
152
2.13
3.85
1.6
1.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
132
936
1.45
3.79
11.1
7.8
mmol/l
9.2
8.1
1.04
127
899
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
40
209
1.94
3.74
5.1
2.9
—
—
—
0
0
(3022621) pH of Urine by Test strip
119
832
1.46
3.69
2.8
2.5
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
68
420
1.65
3.65
3.6
3.6
%
47.1
50.5
0.55
68
413
(3000034) Microalbumin [Mass/volume] in Urine
22
91
2.44
3.64
2.5
3.0
mg/l
20.3
26.5
0.17
13
63
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
25
110
2.29
3.62
2.4
2.5
%
9.1
11.8
0.97
18
62
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
91
605
1.53
3.60
6.0
5.2
mmol/l
23.7
24.0
0.37
83
556
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
50
285
1.78
3.59
1.5
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
128
914
1.43
3.56
1.1
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
91
607
1.53
3.55
1.4
1.5
u/l
10.1
8.2
0.71
75
480
(3042631) Mycobacterium sp identified in Specimen
26
118
2.22
3.52
4.3
2.4
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
39
207
1.91
3.50
1.6
1.7
mmol/l
8.5
7.3
1.54
26
124
(40768804) Tissue Pathology biopsy report
572
5005
1.22
3.49
2.3
1.9
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
48
276
1.76
3.36
1.5
1.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
15
53
2.85
3.36
1.6
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
15
53
2.85
3.36
1.6
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
15
53
2.85
3.36
1.6
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
15
53
2.85
3.36
1.6
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
119
848
1.43
3.36
1.3
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
362
3030
1.25
3.35
4.5
4.1
mg/mmol
18.6
9.2
1.42
230
1968
(3004616) Nuclear Ab [Presence] in Serum
30
148
2.05
3.31
1.6
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
54
324
1.69
3.27
1.8
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
34
619
0.54
3.24
1.3
1.4
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
9
19
4.76
3.24
1.4
1.3
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
12
38
3.17
3.21
1.1
1.1
%
89.2
90.9
0.06
12
38
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
12
38
3.17
3.21
1.1
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
8
15
5.35
3.19
1.1
3.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
78
516
1.54
3.19
1.7
1.7
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
114
817
1.42
3.13
1.6
1.6
mu/l
308.4
303.0
0.06
105
738
(3000330) Specific gravity of Urine by Test strip
82
552
1.51
3.10
3.7
2.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1399
13415
1.25
3.02
16.6
11.9
%
40.1
40.4
0.82
1068
10641
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
47
278
1.71
3.02
2.4
3.6
%
56.2
55.2
0.21
47
278
(3018677) aPTT in Platelet poor plasma by Coagulation assay
213
1697
1.29
2.96
2.5
2.3
s
30.2
29.7
0.57
207
1648
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1371
13126
1.24
2.95
4.5
4.1
mmol/l
2.8
2.8
0.48
1256
12310
(3011412) CD3 cells [#/volume] in Blood
27
135
2.02
2.91
2.3
2.7
e9/l
1.2
1.3
0.31
20
79
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
94
662
1.44
2.86
1.1
1.1
—
2.2
—
0
8
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1355
12969
1.23
2.85
4.2
3.8
mmol/l
4.7
4.7
1.24
1252
12243
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
176
1376
1.31
2.82
4.5
3.8
%
30.4
31.9
1.23
135
979
(3030905) Polymorphonuclear cells [#/volume] in Blood
45
270
1.68
2.77
2.4
3.4
e9/l
4.0
3.9
0.08
45
270
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
152
1171
1.33
2.71
1.3
1.2
iu/ml
90.3
140.7
1.89
59
449
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
6
10
6.02
2.70
2.3
3.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
340
2892
1.22
2.68
3.7
3.3
mg/l
408.9
308.4
0.17
229
1889
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
15
61
2.47
2.62
1.5
1.1
iu/ml
411.7
193.6
0.61
15
61
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
66
442
1.51
2.60
1.2
1.1
u/ml
0.6
2.4
2.51
35
201
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
30
163
1.86
2.58
1.4
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
49
308
1.61
2.54
2.7
1.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1299
12426
1.20
2.51
3.7
3.4
mmol/l
1.3
1.3
2.80
1187
11640
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
23
115
2.01
2.51
1.1
1.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
58
381
1.54
2.51
1.3
1.3
titre
62.9
87.7
—
7
39
(3048929) Epstein Barr virus Ab [Presence] in Serum
97
706
1.40
2.50
1.3
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
30
166
1.82
2.45
1.3
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
45
280
1.62
2.44
1.7
1.8
—
—
—
0
0
(3000012) Reticulocyte production index
13
51
2.56
2.44
1.1
1.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
32
181
1.78
2.44
1.8
1.6
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
66
449
1.49
2.43
1.1
1.1
u/ml
4.6
5.5
0.08
11
68
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
124
944
1.34
2.42
2.2
2.4
au/ml
10.2
20.0
—
5
70
(3017143) Hepatitis C virus Ab [Presence] in Serum
258
2159
1.23
2.38
1.8
1.6
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
40
244
1.65
2.35
2.3
2.4
g/l
131.5
133.2
0.21
30
188
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
368
3193
1.20
2.34
1.7
1.6
mmol/l
1.4
1.4
0.87
308
2745
(3047181) Lactate [Moles/volume] in Blood
48
308
1.57
2.32
6.9
7.8
mmol/l
1.4
1.2
0.76
42
265
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
308
1.57
2.32
1.3
2.1
g/l
10.0
10.2
0.14
43
273
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
9
28
3.23
2.30
1.0
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
36
215
1.69
2.30
1.4
1.4
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
22
113
1.96
2.25
1.3
1.1
u/l
76.5
66.0
0.11
17
73
(3000492) Spirometry study
173
1393
1.27
2.25
1.4
1.4
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
47
303
1.57
2.23
1.7
1.7
e6/l
682.5
2135.8
0.60
40
242
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
47
303
1.57
2.23
1.6
1.7
e6/l
2.7
15.7
2.58
33
233
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
9
29
3.11
2.22
1.2
1.6
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
13
54
2.42
2.20
2.3
2.6
e6/l
245.0
303.4
—
8
29
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1340
12903
1.19
2.17
4.2
3.7
mmol/l
1.4
1.5
3.40
1237
12116
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
21
108
1.96
2.15
1.8
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
342
2970
1.19
2.15
3.7
3.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
32
189
1.71
2.14
1.4
3.7
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
39
243
1.62
2.14
1.4
3.5
mg/l
30.8
71.4
0.85
32
188
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
39
243
1.62
2.14
1.4
3.5
mg/l
23.6
30.7
1.11
32
187
(3024980) IgG subclass 4 [Mass/volume] in Serum
35
212
1.66
2.14
2.1
1.6
g/l
0.8
0.8
0.03
25
159
(3019060) Gas panel - Arterial blood
82
598
1.39
2.13
5.4
5.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
44
283
1.57
2.12
3.5
2.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
19
95
2.01
2.11
1.5
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
19
95
2.01
2.11
1.5
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
19
95
2.01
2.11
1.5
1.5
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
23
124
1.87
2.07
1.9
2.1
pg
32.6
32.4
0.08
23
124
(3027135) IgG subclass 1 [Mass/volume] in Serum
23
124
1.87
2.07
1.8
1.2
g/l
7.7
6.3
0.97
16
84
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
42
269
1.58
2.07
4.9
4.3
u/ml
0.4
0.4
0.27
27
151
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
10
5.01
2.07
1.2
1.5
ng/l
78.4
95.0
—
5
10
(4010399)
104
792
1.33
2.06
1.5
1.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
24
132
1.83
2.04
2.5
3.1
nmol/l
0.9
0.9
0.05
18
101
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
226
1898
1.22
2.03
2.6
2.9
mmol/l
2.4
2.4
1.39
186
1676
(3040151) Glucose [Moles/volume] in Capillary blood
23
125
1.85
2.03
1.5
5.0
mmol/l
6.5
6.6
0.06
15
106
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
33
200
1.66
2.02
1.5
1.5
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
11
44
2.51
2.01
1.5
1.1
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
14
63
2.23
2.01
1.9
3.0
ug/l
2.1
1.0
1.04
14
57
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
93
700
1.35
2.00
1.3
1.3
miu/ml
165.1
240.9
1.95
40
351
(3010726) Horse dander IgE Ab [Units/volume] in Serum
56
386
1.47
1.99
1.1
1.1
u/ml
1.4
2.9
1.01
17
102
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
26
148
1.77
1.99
1.4
1.6
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
59
412
1.45
1.96
6.5
6.6
mg/l
1.6
1.3
1.26
54
388
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
315
2738
1.19
1.96
4.0
4.2
ug/l
2.6
2.1
0.28
285
2485
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
84
1114
0.74
1.95
1.2
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
12
51
2.36
1.95
1.2
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
47
314
1.51
1.94
1.3
2.1
g/l
3.0
3.1
0.23
41
256
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
5
11
4.56
1.94
7.2
2.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
13
58
2.25
1.91
1.2
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
25
143
1.76
1.89
1.3
1.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
49
333
1.49
1.88
1.3
2.1
g/l
3.6
3.7
0.42
40
249
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
49
333
1.49
1.88
1.3
2.1
g/l
7.4
7.3
0.12
42
264
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
49
333
1.49
1.88
1.3
2.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
373
3301
1.17
1.87
5.2
4.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
9
34
2.66
1.86
2.1
1.9
umol/l
21.6
14.5
—
9
34
(3019150) Specific gravity of Urine by Refractometry
330
2896
1.17
1.83
4.2
3.4
kg/l
1.0
1.0
0.64
52
424
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
10
40
2.51
1.83
1.7
1.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
24
137
1.76
1.83
2.2
2.1
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
22
123
1.80
1.80
2.2
2.6
—
41.7
—
0
16
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
49
337
1.47
1.78
1.6
1.8
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
11
47
2.35
1.77
3.7
2.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
46
313
1.48
1.77
1.2
1.3
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
22
124
1.78
1.76
1.9
1.2
g/l
3.1
2.8
0.48
16
83
(3024139) IgG subclass 3 [Mass/volume] in Serum
22
124
1.78
1.76
1.9
1.2
g/l
0.4
0.4
0.30
16
82
(3050129) First trimester maternal screen panel - Serum or Plasma
71
948
0.74
1.75
1.5
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
12
54
2.23
1.74
2.3
2.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
47
323
1.47
1.73
2.6
2.4
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
8
30
2.67
1.72
1.8
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
8
30
2.67
1.72
1.8
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
8
30
2.67
1.72
1.8
1.0
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
25
148
1.70
1.70
1.5
1.5
pmol/l
235.8
359.5
1.85
18
110
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
27
164
1.66
1.68
2.0
2.5
nmol/l
22.4
22.0
0.04
27
156
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
48
334
1.45
1.67
1.2
1.4
pmol/l
85.4
155.1
0.74
43
324
(3002256) Pathology report gross observation
182
1530
1.21
1.65
1.3
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
16
83
1.94
1.64
1.1
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
28
173
1.63
1.64
1.3
1.5
—
—
—
0
0
(4062490)
22
127
1.74
1.64
1.9
1.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
11
49
2.25
1.63
1.2
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
60
437
1.39
1.63
3.1
4.0
g/l
0.2
0.3
0.43
33
198
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
36
238
1.52
1.60
1.1
2.1
g/l
0.0
0.0
0.00
36
225
(3017446) Testosterone [Moles/volume] in Serum or Plasma
126
1022
1.25
1.60
2.3
2.2
nmol/l
11.6
12.6
0.49
106
921
(21494755) Public health laboratory ask at order entry panel
154
1844
0.82
1.60
1.3
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
58
422
1.39
1.59
2.0
2.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
21
121
1.74
1.58
4.1
3.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
7
26
2.70
1.58
1.1
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
11
50
2.21
1.57
1.2
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
20
114
1.76
1.56
1.2
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
26
160
1.63
1.56
1.3
1.5
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
36
240
1.51
1.55
1.1
2.1
g/l
0.0
0.0
0.00
36
226
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
15
78
1.93
1.54
1.3
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
10
44
2.28
1.53
1.7
1.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
20
115
1.75
1.52
1.2
1.2
—
—
—
0
0
(3019174) dRVVT (LA screen)
5
15
3.34
1.52
1.6
1.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
15
3.34
1.52
2.2
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
17
93
1.84
1.51
4.2
2.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
27
2.60
1.51
1.4
1.1
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
12
58
2.08
1.49
1.2
1.1
u/l
79.4
73.5
0.07
12
51
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
14
72
1.95
1.49
3.4
3.9
mg/l
6.7
8.1
—
8
62
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
37
251
1.48
1.48
1.0
1.0
u/ml
2.6
2.8
0.05
15
127
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
22
355
0.61
1.48
1.1
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
9
37
2.44
1.48
2.0
1.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
108
870
1.26
1.47
2.9
3.3
pmol/l
4.7
4.6
0.10
88
781
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
38
260
1.47
1.46
1.1
2.1
g/l
0.0
0.0
0.50
38
246
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
30
195
1.55
1.46
1.7
1.7
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
9
38
2.38
1.45
2.8
2.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
5
16
3.13
1.44
1.6
1.3
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
12
59
2.04
1.43
46.2
32.9
ug/l
124.9
132.1
0.11
12
51
(3029396) Erythrocyte agglutination [Presence] in Blood
12
59
2.04
1.43
2.8
3.3
—
—
—
0
0
(4015189)
6
22
2.73
1.43
2.3
3.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
216
1871
1.18
1.43
2.1
2.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
39
2.31
1.43
1.8
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
39
2.31
1.43
1.8
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
41
287
1.44
1.42
1.5
1.6
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
55
406
1.37
1.41
1.1
1.1
u/ml
5.4
6.1
0.10
30
229
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
39
271
1.45
1.40
7.1
5.6
iu/ml
798.4
309.5
—
5
31
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
21
126
1.68
1.40
1.0
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
135
1611
0.82
1.37
1.4
1.6
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
18
104
1.74
1.37
1.7
1.7
mmol/l
6.6
6.3
0.22
18
78
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
6
23
2.61
1.37
1.2
1.0
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
5
17
2.95
1.36
1.2
1.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
25
159
1.58
1.35
1.3
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
9
42
2.15
1.33
1.8
1.9
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
18
105
1.72
1.33
2.7
2.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
40
0.00
1.32
0.0
1.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
72
560
1.30
1.32
1.4
1.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
36
250
1.45
1.31
2.6
3.0
mg/l
24.8
25.5
0.05
22
154
(3024471) HLA-A [Type]
9
43
2.10
1.30
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
9
43
2.10
1.30
1.1
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
9
43
2.10
1.30
6.9
3.9
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
14
76
1.85
1.30
1.1
1.3
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
16
91
1.77
1.29
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
16
91
1.77
1.29
1.0
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
11
55
2.01
1.27
2.3
1.3
nmol/l
152.4
142.7
0.14
11
55
(4146454)
16
92
1.75
1.25
2.9
2.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
49
364
1.36
1.24
1.2
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
45
2.01
1.23
3.0
3.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
9
45
2.01
1.23
2.1
1.2
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
9
45
2.01
1.23
1.0
1.1
%
—
18.0
—
0
5
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
9
45
2.01
1.23
2.1
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
31
212
1.47
1.23
1.0
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
52
391
1.34
1.22
1.1
1.1
u/ml
1.1
1.2
0.04
25
185
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
5
19
2.64
1.21
1.2
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
28
188
1.50
1.21
1.7
1.4
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
8
37
2.17
1.21
1.1
1.3
—
9.3
—
0
9
(3014133) Dog dander IgE Ab [Units/volume] in Serum
43
314
1.38
1.21
1.1
1.0
u/ml
14.7
3.9
0.39
18
131
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
15
86
1.75
1.19
1.3
1.7
—
—
—
0
0
(3004451) EKG impression Narrative
8
38
2.11
1.18
1.3
1.3
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
20
2.50
1.15
2.6
1.8
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
5
20
2.50
1.15
3.2
2.1
mmol/l
1.2
1.2
—
5
20
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
24
158
1.53
1.15
1.2
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
33
233
1.42
1.13
1.1
1.1
iu/ml
19.8
134.5
—
6
70
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
19
119
1.60
1.11
1.2
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
21
135
1.56
1.11
1.0
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
32
226
1.42
1.10
2.2
1.7
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
16
96
1.67
1.10
1.8
1.6
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
16
96
1.67
1.10
1.1
1.3
—
65.5
—
0
11
(3003181) Sodium [Moles/volume] in Urine
24
160
1.51
1.09
1.5
1.3
mmol/l
57.8
68.4
0.59
14
139
(4027681)
17
104
1.64
1.09
1.2
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
5
21
2.38
1.09
1.0
1.4
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
21
2.38
1.09
1.8
1.3
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
12
66
1.82
1.09
1.2
1.0
—
6.2
—
0
9
(3018405) Lactate [Moles/volume] in Arterial blood
45
338
1.34
1.09
4.4
3.8
mmol/l
1.4
1.4
0.09
45
331
(3025130) Human papilloma virus identified in Specimen
31
219
1.42
1.07
1.9
1.8
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
16
97
1.66
1.06
1.0
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
10
52
1.93
1.06
2.0
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
9
46
1.96
1.03
1.7
1.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
10
53
1.89
1.01
2.0
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
38
282
1.36
1.00
1.1
1.1
u/ml
7.5
4.7
0.34
20
126
(3043238) Trisomy 21 risk [Likelihood] in Fetus
46
595
0.77
1.00
1.7
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
52
405
1.29
1.00
1.3
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
32
231
1.39
1.00
6.3
4.7
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
45
583
0.77
0.99
1.6
1.5
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
7
134
0.52
0.98
1.6
1.6
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
9
49
1.84
0.98
1.0
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
45
581
0.77
0.97
1.6
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
51
399
1.29
0.95
1.4
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
79
951
0.82
0.94
1.6
1.6
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
47
600
0.78
0.94
1.4
1.5
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
7
37
1.90
0.94
1.0
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
37
1.90
0.94
1.3
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
54
427
1.27
0.93
1.0
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
59
732
0.80
0.93
1.6
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
59
732
0.80
0.93
1.6
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
56
445
1.27
0.93
1.2
1.3
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
6
27
2.23
0.93
1.2
11.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
474
4437
1.10
0.93
1.6
1.6
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
59
731
0.80
0.92
1.6
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
59
730
0.80
0.91
1.6
1.4
—
—
—
0
0
(4024509)
15
94
1.60
0.90
1.5
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
34
254
1.35
0.88
2.6
2.6
ug/min
248.2
133.9
0.39
23
161
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
82
685
1.21
0.88
1.4
2.6
u/ml
101.5
45.7
0.53
75
659
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
154
0.58
0.88
1.3
1.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
85
713
1.20
0.88
2.4
1.9
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
49
387
1.27
0.87
1.4
1.3
u/ml
184.3
238.5
0.97
27
228
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
30
2.00
0.87
2.2
2.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
30
2.00
0.87
2.2
2.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
44
343
1.29
0.86
1.3
1.4
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
35
264
1.33
0.86
1.1
1.0
u/ml
0.1
0.5
—
8
69
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
109
938
1.17
0.85
3.7
4.3
ug/l
5.8
25.6
1.36
81
757
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
21
145
1.45
0.85
1.1
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
17
112
1.52
0.85
1.5
1.7
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
16
104
1.54
0.84
1.9
1.5
g/l
0.8
1.0
1.43
16
104
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
44
345
1.28
0.83
1.5
1.2
u/ml
28.4
11.5
—
9
59
(3016244) Insulin [Units/volume] in Serum or Plasma
19
129
1.48
0.83
2.9
3.3
mu/l
18.1
30.3
1.14
19
120
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
171
1526
1.13
0.82
1.8
1.9
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
23
163
1.42
0.82
1.2
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
15
97
1.55
0.81
1.0
1.1
u/l
0.9
1.0
—
5
50
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
32
241
1.33
0.81
1.1
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
33
250
1.33
0.80
1.6
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
37
286
1.30
0.79
1.5
1.6
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
43
340
1.27
0.78
1.5
1.2
u/ml
1.9
2.5
—
9
38
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
129
1459
0.87
0.76
1.5
1.5
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
10
59
1.70
0.76
1.2
1.6
nmol/l
1.7
1.1
—
10
47
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
9
53
1.70
0.75
1.7
1.2
—
71.3
—
0
8
(3012494) Peanut IgE Ab [Units/volume] in Serum
11
67
1.65
0.75
1.4
1.1
u/ml
20.1
5.9
—
5
41
(3014765) Yersinia sp identified in Stool by Organism specific culture
51
414
1.24
0.75
1.3
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
178
1604
1.12
0.75
2.7
2.7
ug/l
0.7
0.7
0.14
108
949
(3037756) Immunofixation for Serum or Plasma
23
167
1.38
0.73
1.1
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
153
1368
1.13
0.73
1.5
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
18
125
1.44
0.72
1.7
1.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
13
84
1.55
0.72
6.3
4.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
68
1.62
0.71
1.4
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
12
76
1.58
0.71
1.3
1.4
u/l
23.3
7.1
—
6
32
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
76
1.58
0.71
1.4
1.1
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
19
134
1.42
0.71
1.3
1.5
—
28.0
—
0
6
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
50
408
1.23
0.71
1.2
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
26
1.93
0.70
1.2
1.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
82
705
1.17
0.68
3.1
2.9
ng/l
217.7
159.3
0.68
71
629
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
27
1.85
0.68
1.0
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
9
59
1.53
0.68
1.1
1.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
356
3339
1.08
0.68
1.8
1.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
51
420
1.22
0.67
1.3
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
15
102
1.47
0.67
1.1
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
14
94
1.49
0.66
1.2
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
14
94
1.49
0.66
1.1
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
7
44
1.59
0.65
1.3
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
14
95
1.48
0.64
1.1
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
5
29
1.73
0.64
1.2
1.8
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
18
129
1.40
0.63
1.4
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
18
129
1.40
0.63
1.4
1.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
8
51
1.57
0.60
5.4
2.0
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
0
20
0.00
0.60
0.0
1.1
—
20.2
—
0
15
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
58
682
0.85
0.60
1.5
1.7
mg/l
5.2
4.3
0.14
43
463
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
43
520
0.82
0.60
1.3
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
79
905
0.87
0.59
4.4
3.1
—
—
—
0
0
(3012565) Volume of 24 hour Urine
10
64
1.57
0.58
1.8
2.7
ml
1813.8
2048.9
—
10
58
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
6
35
1.72
0.57
2.8
2.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
22
167
1.32
0.57
1.5
1.7
—
—
—
0
0
(4035726)
107
955
1.13
0.56
1.4
1.4
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
39
320
1.22
0.56
2.4
2.3
umol/l
4.8
5.5
0.31
25
243
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
6
37
1.62
0.55
1.3
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
6
37
1.62
0.55
1.3
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
10
65
1.54
0.55
1.7
3.3
u/ml
571.6
740.9
—
10
65
(40768795) Lymph node Pathology biopsy report
15
107
1.41
0.55
1.1
1.2
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
6
38
1.58
0.54
1.0
2.3
nmol/l
5.8
4.7
—
6
38
(3038177) Helicobacter pylori Ab [Presence] in Serum
20
261
0.76
0.54
1.2
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
6
39
1.54
0.53
1.3
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
31
250
1.24
0.52
1.7
1.7
e6/l
16788.5
11394.9
0.22
22
189
(3023410) Appearance of Cerebral spinal fluid
19
143
1.33
0.52
2.5
2.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
16
117
1.37
0.52
1.3
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
40
1.50
0.51
1.3
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
9
64
1.41
0.51
1.0
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
39
324
1.21
0.51
1.5
1.4
u/ml
115.4
105.5
—
9
60
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
233
2179
1.08
0.50
3.2
3.7
%
24.6
20.9
1.94
89
906
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
41
1.47
0.50
1.3
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
6
41
1.47
0.50
2.0
1.7
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
6
41
1.47
0.50
1.2
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
30
243
1.24
0.49
5.1
3.9
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
12
84
1.43
0.49
1.8
1.8
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
15
110
1.37
0.48
2.1
2.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
30
244
1.23
0.48
1.1
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
7
47
1.49
0.47
1.4
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
63
718
0.87
0.47
1.6
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
122
1336
0.91
0.47
5.9
5.6
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
19
146
1.30
0.47
1.1
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
10
68
1.47
0.47
1.2
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
7
48
1.46
0.46
2.7
2.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
63
552
1.15
0.46
1.5
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
24
192
1.25
0.45
1.6
1.5
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
15
112
1.34
0.44
2.1
2.6
mmol/l
106.1
105.4
0.28
15
112
(3041354) Potassium [Moles/volume] in Venous blood
15
112
1.34
0.44
2.1
2.6
mmol/l
4.0
4.0
0.27
15
112
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
31
256
1.21
0.44
1.1
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
69
1.45
0.44
1.1
1.7
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
9
127
0.71
0.43
1.0
1.4
nmol/l
27.6
30.6
—
9
110
(40765096) Chromosome analysis panel by Banding
5
31
1.61
0.43
1.0
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
71
796
0.89
0.42
1.6
1.5
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
5
32
1.56
0.42
1.4
2.4
e6/l
21260.0
55463.8
—
5
20
(4211845)
8
58
1.38
0.41
5.4
1.9
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
58
1.38
0.41
1.1
1.8
—
—
—
0
0
(4038314)
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
59
1.36
0.41
2.1
2.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
59
1.36
0.41
2.1
2.1
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
8
60
1.33
0.40
1.1
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
12
88
1.37
0.40
1.4
1.2
ratio
1.0
1.1
—
6
39
(4034850)
44
381
1.16
0.39
9.1
8.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
31
261
1.19
0.38
1.1
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
539
5226
1.05
0.37
2.6
2.4
—
—
—
0
0
(44813793)
14
107
1.31
0.37
1.1
1.0
—
—
—
0
0
(4268621)
12
158
0.76
0.37
2.0
2.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
17
134
1.27
0.37
1.6
1.8
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
6
44
1.36
0.34
1.5
3.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
45
1.33
0.33
1.0
1.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
89
0.67
0.33
1.0
1.2
—
—
—
0
0
(44806118)
12
154
0.78
0.32
1.8
1.5
—
—
—
0
0
(44790048)
12
154
0.78
0.32
1.8
1.5
—
—
—
0
0
(44790047)
12
154
0.78
0.32
1.8
1.5
—
—
—
0
0
(44790049)
12
154
0.78
0.32
1.8
1.5
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
7
52
1.35
0.31
1.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
34
297
1.15
0.29
1.3
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
7
56
1.25
0.29
1.0
1.4
—
—
—
0
0
(3020891) Body temperature
43
383
1.13
0.28
5.3
4.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
34
298
1.14
0.28
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
14
113
1.24
0.26
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
14
113
1.24
0.26
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
14
113
1.24
0.26
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
14
113
1.24
0.26
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
14
113
1.24
0.26
1.2
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
32
282
1.14
0.25
1.2
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
15
123
1.22
0.25
1.5
1.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
14
114
1.23
0.25
1.1
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
14
114
1.23
0.25
1.2
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
11
87
1.27
0.24
5.4
3.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
10
78
1.28
0.24
1.0
1.1
miu/ml
1051.2
1552.8
—
10
78
(21494890) Protein electrophoresis panel - 24 hour Urine
6
84
0.71
0.24
1.0
2.3
—
—
—
0
0
(1002224) Polysomnography panel
66
611
1.08
0.23
1.0
1.1
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
5
39
1.28
0.23
1.8
2.3
e6/l
20744.0
876.7
—
5
33
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
30
337
0.89
0.22
1.9
1.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
7
91
0.77
0.22
1.1
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
19
163
1.17
0.21
1.1
1.2
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
14.2
—
0
12
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
43
1.16
0.21
1.2
1.0
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
13
0.00
0.21
0.0
1.1
—
7.9
—
0
13
(3021706) Oxygen [Partial pressure] in Arterial cord blood
0
13
0.00
0.21
0.0
1.1
—
2.7
—
0
13
(40768793) Breast Pathology biopsy report
27
303
0.89
0.20
1.1
1.3
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
14
0.00
0.20
0.0
1.1
—
27.7
—
0
9
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
48
1.25
0.20
1.3
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
21
183
1.15
0.20
1.3
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
22
193
1.14
0.19
1.2
1.3
—
—
—
0
0
(3036489) Thrombin time
52
481
1.08
0.19
2.8
2.8
s
20.5
21.2
0.72
44
426
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
50
462
1.08
0.19
1.8
1.7
iu/ml
0.1
0.2
0.24
12
81
(40768800) Prostate Pathology biopsy report
13
154
0.84
0.19
1.1
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
71
667
1.07
0.18
1.7
1.7
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
25
223
1.12
0.18
1.2
1.3
u/ml
1.7
6.6
—
9
92
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
280
2730
1.03
0.16
1.4
1.5
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
5
70
0.71
0.16
1.0
2.8
ug/l
18.4
141.1
—
5
59
(3036071) Salmonella sp Ab [Titer] in Serum
8
69
1.16
0.16
1.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
27
244
1.11
0.16
1.1
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
12
139
0.86
0.14
1.0
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
17
151
1.13
0.13
1.5
2.0
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
25
228
1.10
0.13
1.2
1.3
u/ml
1.4
6.0
—
10
80
(4281824)
13
113
1.15
0.13
1.2
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
11
94
1.17
0.13
1.1
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
17
152
1.12
0.12
1.8
1.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
20
182
1.10
0.11
1.3
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
28
260
1.08
0.10
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
258
2625
0.98
0.10
1.8
1.7
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
5
46
1.09
0.09
1.0
1.1
—
92.3
—
0
25
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
5
46
1.09
0.09
1.0
1.0
—
91.9
—
0
25
(3044242) Glucose [Moles/volume] in Arterial blood
5
47
1.06
0.09
1.8
3.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
6
57
1.05
0.08
1.0
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
65
0.77
0.08
1.6
1.8
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
6
71
0.84
0.07
8.3
5.7
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
6
71
0.84
0.07
4.2
2.9
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
8
76
1.05
0.07
1.5
1.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1242
12461
0.99
0.07
19.2
14.0
g/l
332.8
333.4
1.32
1229
12363
(21494434) Karyotype in Bone marrow
9
87
1.03
0.07
1.4
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
219
2159
1.02
0.07
1.6
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
24
226
1.06
0.06
1.2
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
20
187
1.07
0.06
1.2
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
100
0.90
0.06
1.4
1.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
9
102
0.88
0.06
1.1
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
10
90
1.11
0.05
1.0
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
11
100
1.10
0.05
2.1
1.9
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
92
938
0.98
0.05
2.1
2.2
ml/min/173m2
77.4
73.8
0.33
39
360
(3004716) Salmonella sp identified in Stool by Organism specific culture
99
976
1.02
0.03
1.5
1.3
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
34
333
1.02
0.01
1.3
1.5
nmol/l
0.2
0.4
2.11
26
269
(3011648) Oxygen content in Venous blood
10
94
1.06
0.01
4.1
6.9
%
9.2
11.1
—
10
94
(3005570) Glucose [Moles/volume] in Urine
13
124
1.05
0.00
1.4
2.0
—
—
—
0
0
(4306422)
21
204
1.03
0.00
1.2
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
23
224
1.03
0.00
1.1
1.1
—
—
—
0
0
(4094501)
28
276
1.01
0.00
1.2
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
167
1672
1.00
0.00
1.8
1.8
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
39
388
1.01
0.00
1.4
1.9
iu/l
3.3
5.3
—
8
144
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
15
147
1.02
0.00
2.0
1.6
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
7
76
0.92
0.00
1.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.4
—
3.2
—
0
5
(3045788) Cell count panel - Pleural fluid
6
64
0.94
0.00
2.0
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
5
49
1.02
0.00
1.4
1.4
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
7
0.00
0.00
0.0
1.1
—
69.0
—
0
7
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
5
0.00
0.00
0.0
1.2
—
8.0
—
0
5
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
6.9
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
7.4
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
202.1
—
0
7
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
382.6
—
0
5
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
86
0.93
0.00
1.9
1.6
—
—
—
0
0
(3013762) Body weight Measured
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
166.8
—
0
5
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
9
95
0.95
0.00
1.2
1.4
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
20
200
1.00
0.00
2.3
2.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
52
0.96
0.00
1.8
1.7
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.1
—
181.4
—
0
7
(3022670) pH of Venous cord blood
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
53
0.94
0.00
1.2
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
6
0.00
0.00
0.0
1.2
—
33.7
—
0
6
(40758358) Immune stain study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
49
1.02
0.00
1.0
1.0
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
7
71
0.99
0.00
1.0
1.3
u/l
6.1
6.3
—
7
57
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
53
0.94
0.00
2.2
4.2
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
84
0.95
0.00
1.1
1.1
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
11.6
—
0
9
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
7
71
0.99
0.00
1.3
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_OTHER_UNSPE_INJURI_ANKLE_FOOT – Other and unspecified injuries of ankle and foot
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).